Moneycontrol PRO
Live Now |Quants League Sep'21 Edition - 5 Days Live Algorithmic Options Trading Virtual Conference brought to you by Moneycontrol Pro

Over 49 crore COVID-19 vaccine doses administered in India

More than 50.29 lakh (50,29,573) vaccine doses were administered on Thursday, according to a provisional report compiled at 7 pm.

August 06, 2021 / 09:02 AM IST

The cumulative number of COVID-19 vaccine doses administered in the country has gone past 49 crore, the Union health ministry said on Thursday.

More than 50.29 lakh (50,29,573) vaccine doses were administered on Thursday, according to a provisional report compiled at 7 pm.

The ministry said 27,26,494 beneficiaries in the age group of 18-44 years received the first dose, while 4,81,823 were administered the second dose of the vaccine on Thursday.

Cumulatively, 16,92,68,754 people in the 18-44 age group have received the first dose and 1,07,72,537 have been administered the second dose of the vaccine since the start of the third phase of the nationwide inoculation drive, the ministry said.

Five states -- Madhya Pradesh, Gujarat, Rajasthan, Maharashtra and Uttar Pradesh -- have administered more than one crore vaccine doses each to beneficiaries in the 18-44 age group.


COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

Also, the first dose of the vaccine has been administered to more than 10 lakh beneficiaries in the said age group each in Andhra Pradesh, Assam, Chhattisgarh, Delhi, Haryana, Jharkhand, Kerala, Telangana, Himachal Pradesh, Odisha, Punjab, Uttarakhand and West Bengal.

On the 202nd day of the vaccination drive (August 5), a total of 50,29,573 vaccine doses were given -- 37,13,231 beneficiaries received the first dose and 13,16,342 received the second dose -- according to the provisional report.

The final report for the day would be compiled by late night.

The vaccination exercise as a tool to protect the most vulnerable population groups in the country from COVID-19 continues to be regularly reviewed and monitored at the highest level, the ministry said.
first published: Aug 6, 2021 09:03 am

stay updated

Get Daily News on your Browser
ISO 27001 - BSI Assurance Mark